These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36765691)

  • 1. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience.
    Aliseda D; Martí-Cruchaga P; Zozaya G; Rodríguez-Fraile M; Bilbao JI; Benito-Boillos A; Martínez De La Cuesta A; Lopez-Olaondo L; Hidalgo F; Ponz-Sarvisé M; Chopitea A; Rodríguez J; Iñarrairaegui M; Herrero JI; Pardo F; Sangro B; Rotellar F
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
    Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
    Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
    Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
    Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
    Lei JY; Yan LN; Wang WT
    World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
    Ettorre GM; Levi Sandri GB; Laurenzi A; Colasanti M; Meniconi RL; Lionetti R; Santoro R; Lepiane P; Sciuto R; Pizzi G; Cianni R; Golfieri R; D'Offizi G; Pellicelli AM; Antonini M; Vennarecci G
    World J Surg; 2017 Jan; 41(1):241-249. PubMed ID: 27495316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort.
    Gupta AN; Gordon AC; Gabr A; Kalyan A; Kircher SM; Mahalingam D; Mulcahy MF; Merkow RP; Yang AD; Bentrem DJ; Caicedo-Ramirez JC; Riaz A; Thornburg B; Desai K; Sato KT; Hohlastos ES; Kulik L; Benson AB; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1117-1128. PubMed ID: 35732931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?
    Bhangui P; Allard MA; Vibert E; Cherqui D; Pelletier G; Cunha AS; Guettier C; Vallee JC; Saliba F; Bismuth H; Samuel D; Castaing D; Adam R
    Ann Surg; 2016 Jul; 264(1):155-63. PubMed ID: 26649581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.
    Le Roux F; Rebibo L; Cosse C; Chatelain D; Nguyen-Khac E; Badaoui R; Regimbeau JM
    J Laparoendosc Adv Surg Tech A; 2018 May; 28(5):553-561. PubMed ID: 29350570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis.
    Li W; Li L; Han J; Wu H
    Clin Transplant; 2018 Mar; 32(3):e13193. PubMed ID: 29315813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK; Kim DG; Moon IS; Lee MD; Park JH
    J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma.
    Villalobos A; Wagstaff W; Guo M; Zhang J; Bercu Z; Whitmore MJ; Cristescu MM; Majdalany BS; Wedd J; Akce M; Magliocca J; Kokabi N
    Can J Gastroenterol Hepatol; 2021; 2021():9926704. PubMed ID: 34336728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure laparoscopic major liver resection after yttrium
    Aliseda D; Martí-Cruchaga P; Zozaya G; Benito A; Lopez-Olaondo L; Rodríguez-Fraile M; Bilbao JI; Hidalgo F; Iñarrairaegui M; Ciria R; Pardo F; Sangro B; Rotellar F
    Langenbecks Arch Surg; 2022 May; 407(3):1099-1111. PubMed ID: 35229168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation.
    Levi Sandri GB; Ettorre GM; Colasanti M; De Werra E; Mascianà G; Ferraro D; Tortorelli G; Sciuto R; Lucatelli P; Pizzi G; Visco-Comandini U; Vennarecci G
    Hepatobiliary Surg Nutr; 2017 Feb; 6(1):44-48. PubMed ID: 28261594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
    Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience.
    Elshamy M; Presser N; Hammad AY; Firl DJ; Coppa C; Fung J; Aucejo FN
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):264-270. PubMed ID: 28603094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
    Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
    Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma.
    Labgaa I; Tabrizian P; Titano J; Kim E; Thung SN; Florman S; Schwartz M; Melloul E
    HPB (Oxford); 2019 Nov; 21(11):1497-1504. PubMed ID: 31005494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.
    Sapisochin G; Bilbao I; Balsells J; Dopazo C; Caralt M; Lázaro JL; Castells L; Allende H; Charco R
    World J Surg; 2010 Sep; 34(9):2146-54. PubMed ID: 20411387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.
    Chan KM; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Lee WC
    Biomed J; 2019 Oct; 42(5):335-342. PubMed ID: 31783994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.